English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
11 results
Method for treatment of cancer by oral administration of modified pectin
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates generally to methods for treating prostate cancer.
BACKGROUND OF THE INVENTION
The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United
Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates generally to methods for treating prostate cancer.
BACKGROUND OF THE INVENTION
The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United
Synergistic combination of honokiol and modified citrus pectin in cancer therapy
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to regimens and therapeutics intended to inhibit the formation, progression and metastatic conversion of a variety of cancers in mammals, including humans. Cancers effectively targeted by this regimen include solid
Pectic enzyme treated pectin, method of producing the same and application thereof
Only registered users can translate articles
Log In/Sign up
RELATED APPLICATIONS
This application claims priority to Taiwan Application Serial Number 100141068, filed on Nov. 10, 2011, which is herein incorporated by reference.
BACKGROUND
1. Field of Invention
The present invention relates to a pectic enzyme treated pectin (PET-pectin) and a method of
Binding of galectin-3 by low molecular weight pectin
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Methods for treating mammals with modified alginates and pectins
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to compositions, and methods of using the same, to protect mammals from, and treat mammals with diseases and conditions, mediated by various agents, including disease agents, heavy metals and other substances that can be
Reduction of galectin-3 levels by plasmapheresis
Only registered users can translate articles
Log In/Sign up
PRIORITY DATA AND INCORPORATION BY REFERENCE
This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention pertains to
Galectin-3 plasmapheresis therapy
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Galectin-3 plasmapheresis therapy
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
